No Data
Pharma Stocks Have Risk of U.S. Tariffs Priced In -- Market Talk
Top Gap Ups and Downs on Monday: AZN, NVS, UL and More
U.S. Stock Outlook | The declines of the three major Equity Index futures have narrowed, fears of recession triggered by tariffs, traders bet on five more rate cuts by the Federal Reserve this year.
On April 7th (Monday) during Pre-Market Trading, the three major U.S. Equity Indexes all declined.
Novartis Secures Third FDA Approval For Its Kidney Disease Portfolio In One Year
Sector Update: Health Care Stocks Lean Lower Premarket Thursday
Bernstein Reaffirms Their Buy Rating on Novartis AG (NOVN)
Rich2023 : No dividends have been received, and the ex-dividend date for NVS has still not been seen.
74128907 :